Adjuvant nivolumab in resected oesophageal or gastroesophageal junction cancer following neoadjuvant chemoradiotherapy

URN:NBN:SI:doc-VH7S9AL82026Arko, RozalaGašljević, GoranaHribernik, NežkaReberšek, Martinadocuments/doc/V/URN_NBN_SI_doc-VH7S9AL8_001.pdfdocuments/doc/V/URN_NBN_SI_doc-VH7S9AL8_001.txt260articlestr. 288-29310.2478/raon-2026-00201318-2099275560707URN:NBN:SI:doc-VH7S9AL8engCroatian Medical Association - Croatian Society of RadiologySlovenian Medical Society - Section of RadiologyRadiology and oncology (Ljubljana)BYadjuvant immunotherapyadjuvantna imunoterapijagastroesophageal junction cancernivolumaboesophageal cancerrak gastroezofagealnega prehodarak požiralnikaAdjuvant nivolumab in resected oesophageal or gastroesophageal junction cancer following neoadjuvant chemoradiotherapySlovenian real-world data